CorMedix CRMD Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's cash provided by (used in) investing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's cash provided by (used in) investing activity, including discontinued operation?
- CorMedix (CRMD) reported cash provided by (used in) investing activity, including discontinued operation of $2.97M in Q1 2026.
- How has CorMedix's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- CorMedix's cash provided by (used in) investing activity, including discontinued operation increased by 1621.9% year-over-year, from -$194.82K to $2.97M.
- What is the long-term trend for CorMedix's cash provided by (used in) investing activity, including discontinued operation?
- Over 3 years (2021 to 2025), CorMedix's cash provided by (used in) investing activity, including discontinued operation has grown at a 224.4% compound annual growth rate (CAGR), from -$9.13M to -$311.73M.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.